Table 6 Prediction of late GU and GI radiotoxicity.
Variable | Occurrence of late GU toxicity | Occurrence of late GI toxicity | ||
|---|---|---|---|---|
p value | OR (95% CI) | p value | OR (95% CI) | |
Age | 0.385 | 1.031 (0.962–1.106) | 0.299 | 1.041 (0.965–1.122) |
Initial PSA value | 0.610 | 1.011 (0.970–1.053) | 0.076 | 1.035 (0.996–1.076) |
Diabetes mellitus type 2 | 0.869 | 1.104 (0.342–3.567) | 0.001 | 0.145 (0.045–0.466) |
Smoking status | 0.871 | 0.920 (0.340–2.495) | 0.634 | 1.278 (0.466–3.503) |
Chronic hypertension | 0.983 | 1.011 (0.394–2.589) | 0.721 | 1.190 (0.457–3.098) |
Type of radiotherapy | 0.716 | 0.843 (0.335–2.117) | 0.511 | 0.724 (0.277–1.895) |
Gleason score | 0.030 | 2.440 (1.092–5.449) | 0.663 | 1.158 (0.598–2.244) |
Risk group | 0.037 | 2.256 (1.052–4.837) | 0.303 | 1.497 (0.695–3.227) |
RILA value | 0.073 | 1.045 (0.996–1.096) | 0.118 | 1.033 (0.992–1.075) |
TGFB1 C-509T genotypes | 0.670 | 0.869 (0.455–1.659) | 0.867 | 1.058 (0.544–2.060) |
TGFB1 Leu10Pro genotypes | 0.662 | 1.170 (0.579–2.362) | 0.975 | 0.989 (0.485–2.015) |
XRCC3 Thr241Met genotypes | 0.215 | 0.644 (0.321–1.292) | 0.993 | 0.997 (0.488–2.037) |
